Allurion Technologies, Inc.
- Close
- May 7, 2026 · +0.00%
- Market cap
- —
- no share count on file
- Filings
- 318
Q1 2026−52.6% FY25 yoy
Q1 2026N/M FY25 yoy
Q1 2026N/M FY25 yoy
FY 2024derivedN/M FY24 yoy
Q1 2026N/M FY25 yoy
Q1 2026−64.8% FY25 yoy
Price
May 7, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $15,230,000 | reported | |
| FY 2024 | 2024-12-31 | $32,110,000 | reported | |
| FY 2023 | 2023-12-31 | $53,467,000 | reported | |
| FY 2022 | 2022-12-31 | $64,211,000 | reported |
Segments
Geography
LineFY2025ShareChange
All Other Countries$11.24M74%−55.8%
Spain$2.15M14%−46.3%
Italy$1.84M12%−31.5%
Chile———
France———
Turkey, New Lira———
Total$15.23M
Surgical & medical instruments & apparatus
Allurion Technologies, Inc. is the 85th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
MDAISpectral AI, Inc.$19.7M33.6%38.5%$43.6MSNOASonoma Pharmaceuticals, Inc.$19.5M36.7%16.3%$6.3MNEPHNephros Inc$18.8M32.7%6.4%$35.5MVVOSVivos Therapeutics, Inc.$17.4M16.0%121.4%$1.9MPROFProfound Medical Corp.$16.1M65.3%264.4%$270.7MBTCYBiotricity Inc.$16.0M16.0%15.0%$995.7K
ALURAllurion Technologies, Inc. (this company)$15.2M52.6%188.8%—
PLSMPulsenmore Ltd.$12.5M—39.6%$9.9MNXGLNexgel, Inc.$11.4M31.5%26.3%$35.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Allurion Technologies, Inc. · CIK 1964979 · Engraved from SEC EDGAR